🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

82 results for “Karyopharm Therapeutics” Clear

  1. Selinexor

    Karyopharm Therapeutics

    Ovarian Carcinoma

    phase 2 small molecule completed

    1 trial

  2. Selinexor

    Karyopharm Therapeutics

    Recurrent Small Cell Lung Carcinoma

    phase 2 small molecule terminated

    1 trial

  3. Selinexor

    Karyopharm Therapeutics

    Relapse Multiple Myeloma

    phase 2 small molecule active

    1 trial

  4. Selinexor

    Karyopharm Therapeutics

    Multiple Myeloma in Relapse

    phase 2 small molecule active

    1 trial

  5. Selinexor

    Karyopharm Therapeutics

    Carcinoma, Neuroendocrine

    phase 2 small molecule completed

    1 trial

  6. Selinexor

    Karyopharm Therapeutics

    Leukemia

    phase 2 small molecule completed

    2 trials

  7. Selinexor

    Karyopharm Therapeutics

    Multiple Myeloma, Refractory

    phase 2 small molecule active

    1 trial

  8. Selinexor

    Karyopharm Therapeutics

    Locally Advanced Unresectable or Metastatic Melanoma

    phase 2 small molecule terminated

    1 trial

  9. Selinexor

    Karyopharm Therapeutics

    Metastatic Colorectal Cancer

    phase 2 small molecule terminated

    1 trial

  10. Selinexor

    Karyopharm Therapeutics

    Relapsed and Refractory Multiple Myeloma

    phase 2 small molecule active

    1 trial

  11. Selinexor

    Karyopharm Therapeutics

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  12. Selinexor

    Karyopharm Therapeutics

    Acute Myeloid Leukemia (AML)

    phase 2 small molecule completed

    3 trials

  13. Selinexor

    Karyopharm Therapeutics

    Acute Myeloid Leukemia (Relapsed/Refractory)

    phase 2 small molecule completed

    1 trial

  14. Selinexor

    Karyopharm Therapeutics

    Non-small Cell Lung Cancer

    phase 2 small molecule terminated

    1 trial

  15. Selinexor

    Karyopharm Therapeutics

    Myeloma Multiple

    phase 2 small molecule terminated

    1 trial

  16. Selinexor

    Karyopharm Therapeutics

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  17. Selinexor

    Karyopharm Therapeutics

    Prostate Cancer

    phase 2 small molecule terminated

    1 trial

  18. Selinexor

    Karyopharm Therapeutics

    Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    phase 2 small molecule terminated

    1 trial

  19. Selinexor

    Karyopharm Therapeutics

    Smoldering Multiple Myeloma

    phase 2 small molecule active

    1 trial

  20. Selinexor

    Karyopharm Therapeutics

    Coronavirus Infection

    phase 2 small molecule completed

    2 trials

  21. Selinexor

    Karyopharm Therapeutics

    Solid Tumor Malignancy

    phase 2 small molecule terminated

    1 trial

  22. Selinexor

    Karyopharm Therapeutics

    Diabetic Foot Ulcers

    phase 2 small molecule terminated

    1 trial

  23. Selinexor

    Karyopharm Therapeutics

    Diffuse Large B-cell Lymphoma

    phase 2 small molecule active

    1 trial

  24. Selinexor

    Karyopharm Therapeutics

    Thymoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources